NM_001243351.2:c.1009G>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001243351.2(NUB1):​c.1009G>A​(p.Val337Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000000692 in 1,445,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

NUB1
NM_001243351.2 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.03

Publications

0 publications found
Variant links:
Genes affected
NUB1 (HGNC:17623): (negative regulator of ubiquitin like proteins 1) This gene encodes a protein that functions as a negative regulator of NEDD8, a ubiquitin-like protein that conjugates with cullin family members in order to regulate vital biological events. The protein encoded by this gene regulates the NEDD8 conjugation system post-transcriptionally by recruiting NEDD8 and its conjugates to the proteasome for degradation. This protein interacts with the product of the AIPL1 gene, which is associated with Leber congenital amaurosis, an inherited retinopathy, and mutations in that gene can abolish interaction with this protein, which may contribute to the pathogenesis. This protein is also known to accumulate in Lewy bodies in Parkinson's disease and dementia with Lewy bodies, and in glial cytoplasmic inclusions in multiple system atrophy, with this abnormal accumulation being specific to alpha-synucleinopathy lesions. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14851218).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NUB1NM_001243351.2 linkc.1009G>A p.Val337Ile missense_variant Exon 10 of 15 ENST00000568733.6 NP_001230280.2 Q9Y5A7-1H3BM74

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NUB1ENST00000568733.6 linkc.1009G>A p.Val337Ile missense_variant Exon 10 of 15 1 NM_001243351.2 ENSP00000454264.2 Q9Y5A7-1H3BM74

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.92e-7
AC:
1
AN:
1445680
Hom.:
0
Cov.:
28
AF XY:
0.00
AC XY:
0
AN XY:
717828
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33196
American (AMR)
AF:
0.00
AC:
0
AN:
42752
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25808
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39520
South Asian (SAS)
AF:
0.0000120
AC:
1
AN:
83062
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52870
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5742
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1102842
Other (OTH)
AF:
0.00
AC:
0
AN:
59888
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 06, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1081G>A (p.V361I) alteration is located in exon 10 (coding exon 10) of the NUB1 gene. This alteration results from a G to A substitution at nucleotide position 1081, causing the valine (V) at amino acid position 361 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.043
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
22
DANN
Uncertain
0.97
DEOGEN2
Benign
0.035
T;T;T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.096
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.81
T;T;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.15
T;T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Uncertain
2.2
.;.;M
PhyloP100
6.0
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.98
N;N;.
REVEL
Benign
0.10
Sift
Benign
0.045
D;T;.
Sift4G
Benign
0.11
T;T;.
Polyphen
0.0020
.;.;B
Vest4
0.23
MutPred
0.22
.;.;Gain of catalytic residue at L342 (P = 0.0594);
MVP
0.30
MPC
0.24
ClinPred
0.67
D
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.089
gMVP
0.33
Mutation Taster
=59/41
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr7-151064968; API